ODDB.org: Open Drug Database

Astellas Pharma AG - Betmiga 50 mg, Retardtabletten

Swissmedic Registration	62755	Sequence	02
Product name	Betmiga 50 mg	Description	Retardtabletten
ATC-Classification	G04BD12	ATC-Description	Mirabegron
Introduction of Sequence	19.05.2014

Composition

mirabegronum 50 mg, macrogolum 2'000'000, macrogolum 8000, hydroxypropylcellulosum, E 321, magnesii stearas, Überzug: hypromellosum, macrogolum 8000, E 172 (flavum), pro compresso obducto.

Packungsbestandteile

Galenic Form

Delayed release tablets

Active Agent	Dose
Mirabegronum	50 mg

BAG: Active Agent	Dose
Mirabegronum	50 mg

Inactive agents	Dose	additional_information
(Flavum)
E 172		color.
E 321
Hydroxypropylcellulosum
Hypromellosum		Überzug
Macrogol	8000
Magnesii Stearas
Pro Compresso Obducto

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
005	30 Tablet(s)	34.22	53.65	B	SL	No
006	90 Tablet(s)	100.72	125.95	B	SL	No

2026	©ywesee GmbH